Psyence Biomedical reported total assets of $17.57M and total liabilities of $0.62M for the quarter ended Mar 2026, up 999.9% year over year. This balance sheet covers 8 quarters of results from Dec 2022 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables - AccuredAcc. Int. Receivables | 0.83M | 0.05M | 0.00M | |||||
| Loans - NetNet Loans | 0.25M | |||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash & EquivalentsCash & Equiv. | 0.13M | 1.34M | 0.61M | 1.63M | 1.93M | 6.14M | 7.15M | 7.44M |
| Receivables - NetNet Receivables | 0.15M | 0.04M | ||||||
| Receivables - OtherOther Receivables | 0.15M | 0.13M | 0.15M | 0.13M | 0.14M | 0.17M | 0.03M | |
| Receivables | 0.30M | 0.19M | ||||||
| Prepaid Assets | 0.25M | 0.08M | 0.02M | 0.08M | 0.16M | 0.25M | 0.26M | 1.26M |
| Current Assets | 1.21M | 1.59M | 0.16M | 1.60M | 2.24M | 6.56M | 7.63M | 9.11M |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment (Net) | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | |||
| Long-Term Investments | 257.73M | -0.04M | 12.52M | 0.22M | 8.06M | |||
| Intangibles | 0.39M | |||||||
| Goodwill & Intangibles | 0.39M | |||||||
| Other Non-Current Assets | 0.03M | -0.60M | 0.03M | 0.03M | 0.04M | 0.05M | 0.05M | |
| Non-Current Assets | 257.73M | 12.52M | 0.01M | 0.76M | 5.18M | 8.46M | ||
| Assets | 258.93M | 1.59M | 12.68M | 1.60M | 2.25M | 7.32M | 12.81M | 17.57M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payables | 0.42M | 1.79M | 1.01M | 1.80M | 0.86M | 0.39M | 0.64M | 0.41M |
| Notes Payables | 0.39M | 1.47M | 1.25M | |||||
| Payables | 0.42M | 1.79M | 1.40M | 1.80M | 2.11M | 0.39M | 0.64M | 0.41M |
| Accumulated Expenses | 0.01M | 0.01M | ||||||
| Other Accumulated Expenses | 1.61M | 1.61M | 1.58M | |||||
| Current Leases | 1.32M | 1.20M | ||||||
| Total Current Liabilities | 14.27M | 0.13M | 28.75M | 0.12M | ||||
| Non-Current Liabilities | ||||||||
| Non-Current Debt | 1.61M | |||||||
| Convertible Debt | 7.66M | 0.05M | ||||||
| Non-Current Deffered Revenue | 13.10M | 13.10M | ||||||
| Preferred Stock Liabilities | 12.57M | |||||||
| Other Non-Current Liabilities | 0.65M | 0.39M | 0.90M | 0.15M | 0.20M | 0.30M | 0.22M | |
| Total Non-Current Liabilities | 272.17M | 28.36M | 0.90M | 3.36M | 0.39M | 0.64M | 0.41M | |
| Total Liabilities | 272.83M | 1.79M | 28.75M | 1.80M | 3.51M | 0.59M | 0.94M | 0.62M |
| Shareholder's Equity | ||||||||
| Total Debt | 2.00M | 1.47M | 1.25M | |||||
| Common Equity | -13.89M | -0.20M | -0.98M | -0.20M | -1.26M | 6.72M | 11.87M | 16.94M |
| Liabilities and Shareholders Equity | 258.93M | 1.59M | 1.60M | 2.25M | 7.32M | 12.81M | 17.57M | |
| Retained Earnings | -13.90M | -6.30M | -16.07M | 57.46M | -54.50M | -56.45M | -58.44M | -63.38M |